CEIS Researchers

Raffaella VITI
Raffaella VITI

CEIS Researcher


Affiliation: University of Tor Vergata

Address: via Columbia n. 2, 00133 Roma

Telephone: 0672595601

Fax: 062020687

Research Interests: Heatlh tecnology assessment (HTA), heath economic evaluation methods, cost-of-illness models development, cost-utility and cost-effectiveness analysis, mathematical modelling approach in health economics outcomes estimate.


Raffaella is graduated in Demographic and Social Statistics Sciences and she holds a Master’s degree in Health Technology Assessment. She has been a research fellow at CEIS since 2016. She works in applied health economics, decision models for health economic evaluation (cost-effectiveness analysis, cost-utility analysis, budget impact analysis, cost-of-Illness studies), Health Technology Assessment (HTA), Value National and Regional Dossier. She is also a teaching and research assistant in Health Economics since 2014.


The 5 most recent Publications 

  • Mennini FS, Marcellusi A, Viti R, Saglio G. Budget Impact analysis of the first-line treatment of Philadelphic chromosomepositive chronic myeloid leukemia (Ph+ CML) adult patients Farmeconomia. Health economics and therapeutic pathways 2017; 18(1): 21-30
  • Marcellusi A, Viti R, Damele F, Cammà C, Taliani G, Mennini FSM. Early Treatment in HCV: Is it a Cost-Utility Option from the Italian Perspective? Clin Drug Investig. 2016
  • Marcellusi A, Viti R, Russo S, Andreoni M, Antinori A, Mennini FSM. Early Treatment in HIV Patients: A Cost–Utility Analysis from the Italian Perspective. Clin Drug Investig. 2016.
  • Marcellusi A, Viti R, Incorvaia C, Burastero SE, Mennini FS. Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study. Recenti Progressi in Medicina. 2015.
  • Marcellusi A, Viti R, Mecozzi A, Mennini FS. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach. The European Journal of Health Economics, 2014.

More CEIS Publications »

Events & Presentations

The 5 most recent Events & Presentations

  • ISPOR 20th Annual European Congress. 4-8 Novembre, 2017. Glasgow. Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH VS human menopausal gonadotropin for woman undergoing IVF. POSTER presentation.
  • AIES Annual Conference 5-6 October 2017. Pavia, Italy. Economic evaluation for the treatment of acute Bacterial Skin and Skin Structure Infections (ABSSSI) from the Italian National payer perspective: introduction of a new treatment into the patient journey. ORAL presentation.
  • AIES Annual Conference October 3-4 Novembre, 2016. Bologna, Italy. Risultati dell’indagine effettuata su un campione di pazienti affetti da acromegalia: una stima dei costi indiretti. ORAL presentation.
  • ISPOR 19th Annual European Congress. 29 October-2 November 2016, Vienna, Austria. Economic Burden of Schizophrenia in Italy: a probabilistic cost of illness analysis. Presentation AWARD finalist.
  • SIHTA 9° National Conference, 13-15 Ottobre 2016, Riva del Garda, Italy. Economic Burden of Schizophrenia in Italy: a probabilistic cost of illness analysis. ORAL presentation.